Mira Pharmaceuticals (MIRA) Research & Development (2022 - 2025)
Mira Pharmaceuticals (MIRA) posted Research & Development of $496543.0 for Q4 2025, up 20.33% sequentially from $412639.0 in Q3 2025, and down 42.36% YoY from $861441.0 in Q4 2024.
Mira Pharmaceuticals (MIRA) Research & Development (2022 - 2025) Analysis & Trends
Mira Pharmaceuticals (MIRA) has 4 years of Research & Development data on file, last reported at $496543.0 in Q4 2025.
- Quarterly Research & Development fell 42.36% year-over-year to $496543.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.7 million (down 47.97% YoY) and the FY2025 annual result came in at $1.7 million, down 47.97% from the prior year.
- Research & Development climbed to $496543.0 in Q4 2025 per MIRA's latest filing, from $412639.0 in the prior quarter.
- The five-year high for Research & Development was $1.1 million in Q3 2024, with the low at $271606.0 in Q1 2023.
- Average Research & Development over 4 years is $638389.5, with a median of $614462.0 recorded in 2024.
- Year-over-year, Research & Development jumped 180.66% in 2024 and tumbled 61.34% in 2025.
- Mira Pharmaceuticals' Research & Development stood at $884757.0 in 2022, then sank by 56.25% to $387123.0 in 2023, then soared by 122.52% to $861441.0 in 2024, then tumbled by 42.36% to $496543.0 in 2025.
- Business Quant data shows MIRA's Research & Development at $496543.0 in Q4 2025, $412639.0 in Q3 2025, and $496197.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 3.51 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 3.53 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 2.47 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -3.49 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 12.59 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 1.72 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 1.37 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 2.49 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Mira Pharmaceuticals | 22.51 Mn | 11.48 Mn | - | 496,543.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 496,543.00 |
| Sep 30, 2025 | 412,639.00 |
| Jun 30, 2025 | 496,197.00 |
| Mar 31, 2025 | 314,404.00 |
| Dec 31, 2024 | 861,441.00 |
| Sep 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 614,462.00 |
| Mar 31, 2024 | 762,276.00 |
| Dec 31, 2023 | 387,123.00 |
| Sep 30, 2023 | 1.02 Mn |
| Mar 31, 2023 | 271,606.00 |
| Dec 31, 2022 | 884,757.00 |
| Sep 30, 2022 | 714,968.00 |